These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1802677)

  • 21. Serum triiodothyronine levels in patients receiving L-thyroxine.
    Kahn A
    Clin Pharmacol Ther; 1976 May; 19(5 Pt 1):523-30. PubMed ID: 1277707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in serum thyroid hormone, thyrotropin and thyroglobulin concentrations during thyroxine therapy in patients with solitary thyroid nodules.
    Morita T; Tamai H; Ohshima A; Komaki G; Matsubayashi S; Kuma K; Nakagawa T
    J Clin Endocrinol Metab; 1989 Aug; 69(2):227-30. PubMed ID: 2753971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects on bone mineral density by treatment of benign nodular goiter with mildly suppressive doses of L-thyroxine in a cohort women study.
    Appetecchia M
    Horm Res; 2005; 64(6):293-8. PubMed ID: 16269872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythrocyte ouabain binding in patients receiving thyroxine.
    Wilcox AH; Levin GE
    Clin Endocrinol (Oxf); 1987 Aug; 27(2):205-12. PubMed ID: 2444369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
    Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Erythrocyte carbonic anhydrase I and zinc concentrations in thyrotoxicosis reflect integrated thyroid hormone levels over the previous few months].
    Yoshida K
    Rinsho Byori; 2007 Jun; 55(6):560-5. PubMed ID: 17657991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoradiometric assay for basal thyroid-stimulating hormone levels: strategy for the management of thyroxine replacement.
    Garces J; Barsano CP
    South Med J; 1988 Sep; 81(9):1127-31. PubMed ID: 3420444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of the optimal thyroxine dose with the TRH test for replacement and suppression therapy].
    Erne P; Staub JJ; Althaus B; Fleig Y; Girard J
    Schweiz Med Wochenschr; 1983 Dec; 113(50):1922-3. PubMed ID: 6420884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levothyroxine therapy and serum free thyroxine and free triiodothyronine concentrations.
    Woeber KA
    J Endocrinol Invest; 2002 Feb; 25(2):106-9. PubMed ID: 11929079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of red blood cell carbonic anhydrase, glucose 6-phosphate dehydrogenase, hexokinase enzyme activities, and zinc concentration in patients with hyperthyroid diseases.
    Odçikin E; Ozdemir H; Ciftçi M; Capoğlu I
    Endocr Res; 2002; 28(1-2):61-8. PubMed ID: 12108790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationship of thyroid-stimulating hormone (TSH), thyroxine (T4), and triiodothyronine (T3) in primary thyroid failure.
    Kumar MS; Safa AM; Deodhar SD; Schumacher OP
    Am J Clin Pathol; 1977 Dec; 68(6):747-51. PubMed ID: 579717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Normal thyroxine and elevated thyrotropin concentrations: evolving hypothyroidism or persistent euthyroidism with reset thyrostat.
    Kabadi UM; Cech R
    J Endocrinol Invest; 1997 Jun; 20(6):319-26. PubMed ID: 9294777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum thyroxine and triiodothyronine responses of hyperthyroid cats to thyrotropin.
    Mooney CT; Thoday KL; Doxey DL
    Am J Vet Res; 1996 Jul; 57(7):987-91. PubMed ID: 8807008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma free thyroxine concentrations in patients receiving levothyroxine for thyroid suppression.
    Hughes JM; Gallagher DL; Olson JE
    Surgery; 1989 Dec; 106(6):951-5. PubMed ID: 2588121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The odyssey of nontoxic nodular goiter (NTNG) in Greece under suppression therapy, and after improvement of iodine deficiency.
    Michalaki M; Kyriazopoulou V; Paraskevopoulou P; Vagenakis AG; Markou KB
    Thyroid; 2008 Jun; 18(6):641-5. PubMed ID: 18578614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of iodide on serum thyroid hormone levels in normal persons, in hyperthyroid patients, and in hypothyroid patients on thyroxine replacement.
    Philippou G; Koutras DA; Piperingos G; Souvatzoglou A; Moulopoulos SD
    Clin Endocrinol (Oxf); 1992 Jun; 36(6):573-8. PubMed ID: 1424182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Discordance of total plasma l-triiodothyronine and l-thyroxine in thyroid diseases].
    Codaccioni JL; Gillioz P; Carayon P
    Ann Endocrinol (Paris); 1980; 41(3):193-202. PubMed ID: 7416706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The hypothalamic-pituitary-thyroid negative feedback control axis in children with treated congenital hypothyroidism.
    Fisher DA; Schoen EJ; La Franchi S; Mandel SH; Nelson JC; Carlton EI; Goshi JH
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2722-7. PubMed ID: 10946871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of thyroid function.
    Surks MI
    Ophthalmology; 1981 Jun; 88(6):476-8. PubMed ID: 6791080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of prednisone on serum thyrotropin, thyroxine and triiodothyronine concentrations in hypothyroid patients.
    Jensen J; Nolan G; Jubiz W
    J Endocrinol Invest; 1978 Apr; 1(2):171-3. PubMed ID: 114570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.